TransMedics Group, Inc. (TMDX) Operating cash flow 2018–2025
TransMedics Group, Inc. (TMDX) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
$192.8MFY2025 · since FY2018: -$26.0M → $192.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $192.8M | +295.1% |
| FY2024 | $48.8M | +474.6% |
| FY2023 | -$13.0M | +71.6% |
| FY2022 | -$45.8M | -58.7% |
| FY2021 | -$28.9M | +4.6% |
| FY2020 | -$30.3M | +6.3% |
| FY2019 | -$32.3M | -24.3% |
| FY2018 | -$26.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More TMDX financial trends
TMDX RevenueTMDX Net incomeTMDX Net marginTMDX Gross profitTMDX Gross marginTMDX Operating incomeTMDX Operating marginTMDX Free cash flowTMDX Capital expendituresTMDX Return on equityTMDX Stock buybacksTMDX Dividends paidTMDX Total assetsTMDX Total liabilitiesTMDX Shareholders’ equityTMDX overview →